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Hideyuki OkanoIt is my great pleasure to announce the launch of new
alliance between our journal, Inflammation and Regen-
eration, and an international publisher, BioMed Central.
Inflammation and Regeneration is the official journal of
the Japanese Society of Inflammation and Regeneration.
Inflammation and Regeneration provides a forum which
covers a wide range of scientific topics in the research
field of inflammation and basic and clinical regenerative
medicine, such as basic biology of somatic stem cells
[1], pluripotency [2], direct reprogramming [3], cell
therapy using iPS cell technology [4], disease modeling
with iPS cell technology [5], immunoregulation by mes-
enchymal stromal cells [6], immunoregulation in regen-
erative medicine [7], tissue homeostasis in health and
disease [8], tissue engineering [9], interaction between
gut microbiota and host immune cells [10], dendritic
cells [11], vascular biology [12], cancer immunology
[13], regulatory T cells and immunomodulation [14],
intestinal immunity and inflammation [15], inflamma-
tion and oxidative stress [16], cellular and molecular
bases for fibrotic diseases [17], and new therapeutics of
autoimmune disorders [18]. As are the cases for these
topics, inflammation research and regenerative medi-
cine are tightly linked research areas in life sciences
and their significance in translational research is rapidly
increasing. To promote globalization of the journal, in-
clusion within PubMed Central, and early acquisition of
an impact factor, we have decided to strengthen the
organization of the journal by establishing this alliance
with an international, reliable publisher. Dedicated to
open research, BioMed Central publishes a large port-
folio of peer-reviewed, open access journals in biology,
clinical medicine, and health. From now on, I, as the
Editor-in-Chief, encourage the submission of manu-
scripts whose scope bridges the fields of inflammation
and regeneration.Correspondence: hidokano@a2.keio.jp
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